205 results
8-K
EX-99.1
LXRX
Lexicon Pharmaceuticals Inc
2 May 24
Lexicon Pharmaceuticals Reports First Quarter 2024
4:07pm
risk factors
IMPORTANT SAFETY INFORMATION
Dosing: Assess renal function and volume status and, if necessary, correct volume depletion prior … to 60 mL/min/1.73 m2) and in patients with heart failure with eGFR < 60 mL/min/1.73 m2. The safety profile of INPEFA across eGFR subgroups
8-K
EX-99.1
LXRX
Lexicon Pharmaceuticals Inc
11 Mar 24
Lexicon Pharmaceuticals Reports Fourth Quarter 2023
7:26am
cardiovascular risk factors
IMPORTANT SAFETY INFORMATION
Dosing: Assess renal function and volume status and, if necessary, correct volume depletion prior … (eGFR 25 to 60 mL/min/1.73 m2) and in patients with heart failure with eGFR < 60 mL/min/1.73 m2. The safety profile of INPEFA across eGFR subgroups
8-K
EX-10.1
LXRX
Lexicon Pharmaceuticals Inc
11 Mar 24
Lexicon Pharmaceuticals Reports Fourth Quarter 2023
7:26am
of occupational health and workplace safety, the environment, or natural resources, or to the use, handling, storage, manufacturing, transportation, treatment
8-K
EX-1.1
zxa q5w57tbc
29 Dec 23
Entry into a Material Definitive Agreement
5:29pm
8-K
EX-99.1
hynjsnt dt9w
8 Nov 23
Lexicon Pharmaceuticals Reports Third Quarter 2023
7:22am
8-K
EX-99.1
gw4rm8
3 Aug 23
Lexicon Pharmaceuticals Reports Second Quarter 2023
4:08pm
8-K
EX-99.1
kle5uo92 3n0pyglx
31 Jul 23
Lexicon Elects Diane E. Sullivan to Board of Directors
4:02pm
8-K
EX-1.1
lnd4grct3z81fscivvb
2 Jun 23
Lexicon Announces Pricing of $125 Million Public Offering and Concurrent Private Placement
4:31pm
424B5
bp24if1n uf3s
1 Jun 23
Prospectus supplement for primary offering
9:08pm
424B5
r4b29c4
31 May 23
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.1
6vaouip4wtib0q
9 Nov 22
Lexicon Pharmaceuticals Reports Third Quarter 2022
4:05pm
8-K
EX-1.1
ooyit mlbs5gl6retb3
29 Jul 22
Lexicon Announces Proposed Public Offering of Common Stock
5:18pm
8-K
stkpi1z6n6xi yg5
30 Jun 22
Lexicon Announces Positive Top-line Results from Phase 2 Proof-of-concept Study of LX9211 In Painful Diabetic Neuropathy
12:52pm